[go: up one dir, main page]

FR2911506B1 - PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION IN THE FORM OF STABILIZED AQUEOUS SUSPENSIONS - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION IN THE FORM OF STABILIZED AQUEOUS SUSPENSIONS

Info

Publication number
FR2911506B1
FR2911506B1 FR0700353A FR0700353A FR2911506B1 FR 2911506 B1 FR2911506 B1 FR 2911506B1 FR 0700353 A FR0700353 A FR 0700353A FR 0700353 A FR0700353 A FR 0700353A FR 2911506 B1 FR2911506 B1 FR 2911506B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
oral administration
aqueous suspensions
stabilized aqueous
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0700353A
Other languages
French (fr)
Other versions
FR2911506A1 (en
Inventor
Claudio Zanichelli
Simona Binacchi
Sandrine Lacoste
Cecilia Sacchetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Priority to FR0700353A priority Critical patent/FR2911506B1/en
Priority to PCT/EP2008/050492 priority patent/WO2008090076A1/en
Publication of FR2911506A1 publication Critical patent/FR2911506A1/en
Application granted granted Critical
Publication of FR2911506B1 publication Critical patent/FR2911506B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0700353A 2007-01-18 2007-01-18 PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION IN THE FORM OF STABILIZED AQUEOUS SUSPENSIONS Active FR2911506B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0700353A FR2911506B1 (en) 2007-01-18 2007-01-18 PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION IN THE FORM OF STABILIZED AQUEOUS SUSPENSIONS
PCT/EP2008/050492 WO2008090076A1 (en) 2007-01-18 2008-01-17 Oral pharmaceutical compositions in the form of stabilised aqueous solutions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0700353A FR2911506B1 (en) 2007-01-18 2007-01-18 PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION IN THE FORM OF STABILIZED AQUEOUS SUSPENSIONS

Publications (2)

Publication Number Publication Date
FR2911506A1 FR2911506A1 (en) 2008-07-25
FR2911506B1 true FR2911506B1 (en) 2009-07-03

Family

ID=38293701

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0700353A Active FR2911506B1 (en) 2007-01-18 2007-01-18 PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION IN THE FORM OF STABILIZED AQUEOUS SUSPENSIONS

Country Status (2)

Country Link
FR (1) FR2911506B1 (en)
WO (1) WO2008090076A1 (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
CZ283428B6 (en) * 1992-04-30 1998-04-15 Schering Corporation Stable hydrated dry pulverized cephalosporin preparation suitable for oral application in the form of a suspension and pharmaceutical composition containing thereof
WO1995009626A1 (en) * 1993-10-01 1995-04-13 Syntex (U.S.A.) Inc. Mycophenolate mofetil high dose oral suspensions
IT1270594B (en) * 1994-07-07 1997-05-07 Recordati Chem Pharm CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN
FR2730163B1 (en) * 1995-02-03 1997-04-04 Jouveinal Lab NOVEL PHARMACEUTICAL COMPOSITION CONTAINING TRIMEBUTINE AND PROCESS FOR THE PREPARATION THEREOF
IT1286496B1 (en) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin ORAL PHARMACEUTICAL COMPOSITION WITH ANTIPYRETIC, ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
BR0109544A (en) * 2000-03-28 2003-06-10 Biochemie Gmbh Granules with hidden flavor
ES2313452T3 (en) * 2004-12-06 2009-03-01 Janssen Pharmaceutica Nv ORAL SUSPENSION THAT MELOXICAM INCLUDES.
WO2007017905A1 (en) * 2005-08-05 2007-02-15 Lupin Limited Oral pharmaceutical suspension compositions of fexofenadine
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic

Also Published As

Publication number Publication date
FR2911506A1 (en) 2008-07-25
WO2008090076A1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
EP2182799A4 (en) SUPRAMOLECULAR FUNCTIONALIZATION OF GRAPHIC NANOPARTICLES FOR DRUG DELIVERY
EP2152195A4 (en) PHARMACEUTICAL PEPTIDE FOR ORAL ADMINISTRATION
FR2934156B1 (en) ORAL ADMINISTRATION MEDICAMENT IN SOLID FORM
EP2341933A4 (en) IMIDAZOQUINOLINE DERIVATIVES LIPIDATED
EP2321640A4 (en) FORMULATION FOR ORAL ADMINISTRATION OF PROTEINS
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
BRPI0917540A2 (en) compound, pharmaceutically acceptable salt, pharmaceutical composition, and use of a pharmacologically acceptable compound or salt
FR2881652B1 (en) MICROPARTICULAR ORAL PHARMACEUTICAL FORM ANTI-MEASURING
FR2892937B1 (en) MICROPARTICULAR ORAL PHARMACEUTICAL FORM ANTI-MEASURING
SMT201400076B (en) Pharmaceutical formulations against the improper use of medicines
HRP20180709T1 (en) PHARMACEUTICAL DOSAGE FORM OF THE CAPSULA, INCLUDING SUSPENSION FORMULATION OF INDOLINON DERIVATIVES
EP1984009A4 (en) PHARMACEUTICAL COMPOSITIONS WITH IMPROVED STABILITY
BRPI0818193A2 (en) compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, and use of a compound
BRPI0913379A2 (en) solid pharmaceutical formulations comprising bibw 2992
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
DK2420223T3 (en) Aqueous pharmaceutical compositions with borate-polyol complexes
BRPI1009392A2 (en) "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
IL201465A0 (en) Self-precipitating pharmaceutical formulations for the modified release of active principle
EP2193795A4 (en) LATANOPROSOUS AQUEOUS PHARMACEUTICAL COMPOSITION
BRPI0812964A2 (en) SOLID ORAL PHARMACEUTICAL DOSAGE FORM
FR2906140B1 (en) GALENIC FORM FOR TRANSMUCOSUS ADMINISTRATION OF ACTIVE INGREDIENTS
FR2940116B1 (en) FORMULATION FOR THE ADMINISTRATION OF HYPOLIPEMIC BY ORAL TRANS-MUCOSAL
IL208325A0 (en) Stabilizing lipis compositions for oral pharmaceutical agents
DK1837019T3 (en) Oral dispersible pharmaceutical compositions
FR2934161B1 (en) MICROPARTICULAR ORAL FORM USEFUL FOR THE MODIFIED RELEASE OF NANOPARTICLES.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19